USPTO serial 97729351
TISSUE 2 TARGET
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 9, 2024
- Examiner
- GAYNOR, BARBARA ANNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TISSUE 2 TARGET?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Brisbane, CA, US
Brisbane, CA, US
ANALYTICAL BIOLOGICAL SERVICES INC.
NEW CASTLE, DE, US
Other trademarks owned by ANALYTICAL BIOLOGICAL SERVICES INC.
Brisbane, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
E. Kate Berezutskaya
E. Kate Berezutskaya Greer, Burns & Crain, Ltd.200 West Madison StreetSuite 2100Chicago, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Biomedical research services; development of new technology for others in the fields of genomics and biotechnology; biomedical research services for human specimen banking and laboratory analyses, namely, designing research protocols, drug research and development, research and development in the pharmaceutical and biotechnology fields concerning human tissue and molecular and cellular assays; genotyping services for research or analysis purposes; structural and functional analysis of genomes; laboratory analysis in the fields of genomics and biotechnology; medical and scientific research in the field of cell and molecular profiling and biomarker discovery; gene isolation and gene expression analysis for scientific research purposes; gene mapping for scientific purposes; gene analysis and biomarker discovery for scientific research purposes | ACTIVE | Nov 10, 2022 |
| 044 | Human organ and tissue bank services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; bioinformatics analysis for medical diagnostic and personalized treatment purposes; DNA analysis and screening for medical diagnostic and treatment purposes; consulting services in the field of biological sequence and bioinformatic processing for medical diagnosis and treatment purposes; medical testing, namely, identifying biological drug targets for diagnostic or treatment purposes | ACTIVE | Nov 10, 2022 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cureline, Inc.
- Other trademarks owned by Cureline, Inc.
- Other trademarks owned by ANALYTICAL BIOLOGICAL SERVICES INC.
- Other trademarks owned by Cureline, Inc.
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TISSUE 2 TARGET
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 3, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Sep 19, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 19, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 19, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 9, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 9, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 23, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 23, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 3, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 15, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 14, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 14, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 14, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 25, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 25, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 25, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 20, 2023 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jan 19, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 26, 2022 | NWAP | NEW APPLICATION ENTERED | — |